It remains uncertain which is the stronger predictor for stroke in older hypertensives, ambulatory pulse pressure (PP) or mean blood pressure (MBP).
R
ecently, there is growing evidence that arterial stiffness is a predictor for cardiovascular events and death. [1] [2] [3] Pulse pressure (PP), which is a pulsatile component of blood pressure (BP), is one of the indicators of arterial stiffness. Many prospective studies have shown that PP is an important predictor of cardiovascular risk, and some studies have demonstrated that PP is a stronger predictor of cardiovascular events than mean BP (MBP; steady component), particularly in an elderly population. 4 -6 However, most of these prospective studies showed that PP is an independent predictor of cardiovascular event used casual BP. Although ambulatory BP is known to be more closely associated with silent target organ damage and cardiovascular risk than clinic BP, there has been only a few prospective studies on the association between ambulatory PP (APP) and cardiovascular risk. [7] [8] [9] Recently, silent cerebral infarct (SCI) is often detected by brain magnetic resonance imaging (MRI) in older subjects, particularly in those with hypertension. 10 -12 Silent cerebral infarct is the strongest predictor of subsequent clinically overt stroke. 11, 12 The association between APP and stroke risk might be related to SCI, and the stroke risk might be augmented when elevated APP is accompanied by SCI.
To investigate whether APP is a risk factor for stroke in relation to SCI in older hypertensives, we prospectively studied the stroke prognosis in 811 older hypertensive Japanese patients in whom ambulatory BP monitoring (ABPM) was performed in the absence of antihypertensive treatment.
Methods

Subjects
This study is based on 811 older subjects (Ͼ50 years of age) diagnosed with essential hypertension, who are the participants of Jichi Medical School ABPM Study Wave 1. 12 This represents 99% of the 821 subjects who were initially enrolled in the study from six participating institutes (three clinics, two hospitals, and one outpatient clinic of the university hospital) between January 1, 1992, and January 1, 1998 . No patient had taken any antihypertensive medication for at least 14 days before the ABPM study, but 51% had a prior history of antihypertensive medication. All of the subjects studied were ambulatory, and all gave informed consent for the study. We excluded from this study patients with renal failure (serum creatinine level Ն176 mmol/L) or hepatic damage, with obvious present illness, or with past history of coronary artery disease, stroke (including transient ischemic attacks [TIA] ), congestive heart failure, or arrhythmia. Of the 811 patients, 515 (64%) agreed to and had a brain MRI. There were no significant differences in the age, gender, PP, or MBP parameters at the baseline, or in the incidence of cardiovascular disease between these 515 subjects and the other 296 subjects without brain MRI examination. This study was approved by the Research Ethics Committee, Department of Cardiology, Jichi Medical School, Japan. All the results of the ABPM and brain MRI were returned to the physicians who followed up the subjects.
Twenty-four-hour ABPM
Noninvasive ABPM was carried out on a weekday with one of three automatic ABPM devices (ABPM-630, Nippon Colin Co., Aichi; TM-2421 or TM-2425, A&D Co., Tokyo, Japan), which recorded BP (by the oscillometric method) and heart rate every 30 min for 24 h. We excluded the subjects in whom we obtained valid BP readings in Ͻ80% of either awake or asleep attempts, and those who reported in our post-ABPM questionnaire that their sleep was severely disturbed by wearing the ABPM. Sleep BP was defined as the average of BPs from the time when the patient went to bed until the time he/she got out of bed, and awake BP as the average of BPs recorded during the rest of the day.
Brain MRI
Brain MRI was carried out using a superconducting magnet with a main strength of 1.5T (MRT200FXII, Toshiba, Tokyo; SIGNA-HorizonVer.5.8, General Electric Co., Tokyo; or Vision, Siemens, Tokyo, Japan) within 3 months of the ABPM. T1-weighted images and T2-weighted images were obtained in the transverse plane with 7.8-to 8.0-mm thick sections. An SCI was defined as a low signal intensity area (3 to 15 mm) on T1-weighted images that was also visible as a hyperintense lesion on T2-weighted images, as described previously.
10,12,13 Multiple SCI was defined as Ն2 SCIs in a person. The MRI images of the subjects were randomly stored and interpreted blind to the subjects' name and characteristics. The interclass (non-SCI ϭ 0, one SCI ϭ 1, multiple SCIs ϭ 2) kappa statistics were 0.70 and 0.80 for inter-reader and intrareader, respectively, in our laboratory.
Follow-up and Events
The patients' medical records were intermittently reviewed after the subjects entered the study for drug therapy and the occurrence of cardiovascular events. The follow-up evaluation was performed during a 20-month period from 1996 to 1998, and the mean follow-up period was 42 months, with a range from 1 to 68 months. If subjects stopped coming to the clinic, we conducted telephone interviews. Events were classified as cardiac events, stroke events, and noncardiovascular deaths. Stroke events included ischemic stroke (cerebral infarction and cerebral embolism), hemorrhagic stroke (cerebral hemorrhage and subarachnoid hemorrhage), and undefined type of stroke, but excluded TIA (transient neurologic deficits that disappear within 24-h after the onset). Cardiac events included fatal and nonfatal acute myocardial infarction, unexplained sudden death within 6 h of the abrupt onset of symptoms, and coronary revascularization. Fatal event was defined when death occurred within 1 month from the event. These events were accepted if documented in the medical records, or if confirmed by a general practitioner. We excluded 15 possible TIA from the stroke events. Of the total 821 eligible subjects at baseline, follow-up was achieved in 811 (99%) subjects, and the data analysis was restricted to these subjects.
Statistical Analysis
Data are expressed as the mean (SD). One-way ANOVA was performed to detect differences among groups in mean values, and the 2 test was used to detect differences among groups in prevalence rates. Adjusted odds ratio and 95% confidence intervals (95% CI) for baseline SCI were calculated using stepwise multiple logistic analysis, and adjusted relative risks (RR) and 95% CI for future stroke risk were calculated using forced or stepwise Cox regression analysis. For the subjects who experienced multiple nonfatal cardiovascular events, the analysis included only the first stroke event. These statistical analyses were performed using SPSS version 8.0 (SPSS Inc., Chicago, IL). Differences with P Ͻ .05, two-tailed, were considered statistically significant.
Results
During the 42-month follow-up period, 59 clinically overt stroke events (38 ischemic strokes, 9 hemorrhagic strokes, 12 unknown subtype), and 20 fatal cardiovascular events (13 fatal strokes and 7 fatal cardiac events) occurred. At the time of the final follow-up, 426 (53%) of the total 811 patients were receiving antihypertensive medications (diuretics, ␣-or ␤-blockers, calcium antagonists, or angio-tensin-converting enzyme inhibitors). Strokes occurred in 32 (8.3%) of 385 untreated hypertensives, and in 27 (6.3%) of 426 treated hypertensives ( 2 ϭ 1.2, P ϭ .28). Table 1 lists baseline characteristics of studied hypertensives with and without future stroke events. The mean age and clinic and ambulatory BP and PP levels and the prevalences of men and smokers were significantly higher, and body mass index (BMI) was significantly lower in the hypertensives who developed future stroke event (stroke group), than in those who did not develop stroke (nonstroke group; Table 1 ). The prevalences of SCI and multiple SCI were significantly higher in the stroke group (n ϭ 43) than in the nonstroke group (n ϭ 472) (86% v 47%, P Ͻ .0001; 31% v 77%, P Ͻ .0001, respectively).
Baseline Characteristics
Stroke Risk and Pulse Pressure and Mean BP
Figs. 1A and C depict the association between PP tertiles and stroke risk unadjusted and adjusted for covariates (age, gender, BMI, diabetes, hyperlipidemia, antihypertensive medication, and MBP) using Cox regression analysis, separated for clinic, 24-h, awake, and sleep BPs. There were marked positive associations between all PP parameters and unadjusted stroke risk; however, after adjustment for covariates, only the clinic and sleep PPs remained significant. Table 2 shows the results of Cox regression analysis, in which the same covariates as in Fig. 1C were included and PP and MBP parameters were considered as continuous variables. For each 10 mm Hg increase in sleep PP, there was an independent 43% (95% CI:16%-75%, P ϭ .001) increase in the stroke risk, and sleep MBP did not yield significance after controlling for sleep PP. On the other hand, for each 10 mm Hg increase in awake MBP, there was an independent 48% (95% CI:21%-81%, P ϭ .0002) increase in the stroke risk, and awake PP did not yield significance after adjusting for awake MBP. Fig. 2 shows the stroke incidence in the subjects separated according to sleep PP and awake MBP. The stroke incidence was 8.7 times higher in the highest risk hypertensives with awake MBP Ն110 mm Hg (the highest tertile) and sleep PP Ն60 mm Hg (the highest tertile) than in the lowest risk hypertensives with low awake MBP Ͻ95 mm Hg (the lowest tertile) and low sleep PP Ͻ50 mm Hg (the lowest tertile). When both sleep PP and awake MBP were entered into the same model including covariates (age, gender, BMI, diabetes, hyperlipidemia, antihypertensive medication), both sleep PP (RR ϭ 1.32, P ϭ .04) and awake MBP (RR ϭ 1.35, P ϭ .01) were associated with stroke risk independently of each other (Table 3) .
Fatal Cardiovascular Events
Fig . 1B shows the association between PP tertiles and fatal cardiovascular event risk unadjusted. After adjusting for the covariates listed in Table 2 (age, gender, BMI, diabe- tes, hyperlipidemia, antihypertensive medication) using Cox regression analysis, all APP parameters (clinic, 24-h, awake, and sleep) were predictors for fatal cardiovascular events (fatal stroke and cardiac events), independently of MBP parameters. For each 10 mm Hg increase in PP, there was an independent 41% (95% CI: 10%-81%, P ϭ .007) increase for clinic BP, 71% (95% CI: 21%-141%, P ϭ .003) increase for 24-h BP, 64% (95% CI:13-137%, pϭ0.01) increase for awake BP, and 63% (95% CI: 21%-121%, P ϭ .002) for sleep BP in the stroke risk, whereas clinic, 24-h, awake, and sleep MBPs did not yield significance after controlling for PP parameters.
Impact of Silent Cerebral Infarct
Then we grouped the 515 subjects who had both ABPM and brain MRI into 258 subjects without SCI and 257 with SCI. There was a positive association between all PP parameters (clinic, 24-h, awake, and sleep) and SCI (data not shown). However, after adjusting for covariates (age, gender, BMI, diabetes, hyperlipidemia, antihypertensive medication) using stepwise multiple logistic regression
FIG. 1. A) Stroke incidence (unadjusted). B) Fatal cardiovascular event incidence (unadjusted). C)
Relative risk for stroke event (adjusted for age, gender, body mass index, diabetes, hyperlipidemia, antihypertensive medication, and mean blood pressure) in each tertile of pulse pressure (PP) parameter. CI ϭ confidence interval. Age, gender (women ϭ 0, men ϭ 1), body mass index, smoking status (absence ϭ 0, presence ϭ 1), diabetes (absence ϭ 0, presence ϭ 1), hyperlipidemia (absence ϭ 0, presence ϭ 1), antihypertensive medication (absence ϭ 0, presence ϭ 1), and clinic, 24-h, awake, and sleep mean BP and pulse pressure were selected for the stepwise Cox regression analysis.
FIG. 2.
Stroke incidence from the first to the third tertile of the distribution of pulse pressure (PP) parameters and awake mean blood pressure (BP).
analysis, MBP parameters (clinic, 24-h, awake, sleep) significantly were associated with SCI (0 ϭ absent, 1 ϭ present); however, none of the PP parameters yielded statistical significance (Table 4) . Stroke occurred in 6 (2.3%) of the non-SCI group, and in 37 (14%) of the SCI group, indicating that SCI is a strong predictor of clinical stroke (RR ϭ 7.1, P Ͻ .0001). The association between SCI (0 ϭ absent, 1 ϭ present) and stroke risk remained significant independently of all parameters of PP and MBP. Fig. 3 shows the positive associations between PP parameters and stroke risk in both the SCI group and non-SCI group. To study the potential mediating role of SCI in the association between PP, MBP, and stroke risk, we added SCI (0 ϭ absent, 1 ϭ present) into the same model as used for the results shown in Table 2 . The impacts of clinic MBP (RR ϭ 1.23, P ϭ .03), awake MBP (RR ϭ 1.38, P ϭ .007), and sleep PP (RR ϭ 1.32, P ϭ .016) on stroke risk remained significant independently of SCI. Instead of 24-h mean BP (independent predictor for stroke event in Table 2 ), 24-h PP appeared to be a significant predictor for stroke event (RR ϭ 1.41, P ϭ .015) in this model that included SCI.
Discussion
This study has first demonstrated that in older hypertensives, the impacts of PP and MBP on stroke risk are different during sleep and awake periods. Sleep PP and awake mean BP were independent predictors for stroke events. These associations were independent of other cardiovascular risk factors and SCI.
Sleep Pulse Pressure
All PP parameters (clinic, 24-h, awake, and sleep) were positively associated with stroke risk. However, after adjusting for covariates, only sleep PP remained significant independently of MBP. Previous studies have not studied the association of PP and MBP with cardiovascular events separately for awake and sleep periods. To consider the possible mechanism for the difference in the association of the PP and MBP with stroke events between the sleep and awake periods, we have to consider diurnal changes of neurohumoral factors. Although PP is totally considered as a global indicator of arterial stiffness, various factors such as stroke volume, rapidity of ventricular ejection, viscoelastic properties of large arteries, and timing of reflected pulse waves from the peripheral sites determine PP. [1] [2] [3] In an acute human study, pulse wave velocity was CI ϭ confidence interval. Age, gender (women ϭ 0, men ϭ 1), body mass index, smoking status (absence ϭ 0, presence ϭ 1), diabetes (absence ϭ 0, presence ϭ 1), hyperlipidemia (absence ϭ 0, presence ϭ 1), antihypertensive medication (absence ϭ 0, presence ϭ 1), awake mean BP, and sleep pulse pressure were selected for the Model 1 of the forced Cox regression analysis. The silent cerebral infarct (absence ϭ 0, presence ϭ 1) was added in Model 2. Abbreviations as in Table 2 .
unaffected by ␤-adrenergic blockade, but was reduced by combined ␣-and ␤-adrenergic blockade, indicating that sympathetic nervous activity affects the functional stiffness of the large artery. 14 In addition, infusion of angiotensin II increases augmentation index, which implies an augmentation of pressure during the late systolic phase, resulting in increased PP. 15 Thus, it is possible that the diurnal variation in these neurohumoral activities will change the PP during different diurnal periods. During the sleep period, parasympathetic activity increases with diminished sympathetic activity. The activity of the reninangiotensin system also decreases during the sleep period. Thus, sleep PP may more closely reflect structural arterial stiffness with less effect on the neurohumoral factors, whereas awake PP may reflect not only structural stiffness but also functional stiffness, which is also affected by diurnal neurohumoral activation. The results of our study indicate that structural arterial stiffness might be a more powerful determinant of stroke event in the elderly hypertensives.
In addition, the marked dilatation of all peripheral arteriole, which usually occurs during night, might lead to a greater decrease in diastolic BP than systolic BP, which consequently discloses the predictive value of sleep PP (superior to that of sleep MBP) for stroke. This phenomenon might be particularly relevant in the elderly. Furthermore, an increased PP itself may be a causal mechanism for plaque disruption. A recent study (European Carotid Surgery Trial) demonstrated that PP is independently associated with carotid plaque ulceration in patients with carotid stenosis, suggesting that pulsatile hemodynamic forces are an important cause of plaque rupture leading to cardiovascular events. 16 
Awake, Twenty-four-hour, and Clinic Pulse Pressure
On the other hand, after adjusting for covariates, awake, 24-h, and clinic PPs were not associated with stroke independently of MBP. Instead, awake, 24-h, and clinic MBPs were independent predictors for future stroke. In previous prospective studies, contradictory results were obtained regarding the association between clinic PP and stroke risk. 4 In the Systolic Hypertension in the Elderly Program (SHEP), both PP and MBP were independent predictors of stroke. 17 In the recent analysis of the Medical Research Council (MRC) Mild Hypertension Trial, stroke risk was best predicted by MBP, 18 and in the European Working Party on Hypertension in the Elderly (EWPHE), MBP was a predictor for stroke even after adjusting for PP, whereas PP did not significantly predict stroke after adjusting for MBP. 4, 19 In contrast, in the Systolic Hypertension in Elderly in Europe (Syst-Eur) and Systolic Hypertension in Elderly in Chinese (Syst-China) studies of elderly patients with isolated systolic hypertension, PP was a stronger predictor of stroke than MBP. 4 One prospective study using ABPM found an independent positive association between 24-h PP and cardiac events, but did not find an independent association between 24-h PP and stroke. 9 However, that study did not analyze separately for sleep and awake periods. In addition, their study population was much younger (mean age, 51 years) than our population (mean age, 72 years). In study populations with different ages, PP seems to have a different impact on stroke, because in another prospective study using ABPM, an independent impact of PP on cardiovascular events was only found in older patients aged 65 years or more. How- ever, MBP was an independent determinant for cardiovascular events in younger adults aged Ͻ65 years. 8 It appears that when the stroke risk is analyzed separately for sleep and awake periods in older hypertensive patients, the association between APP and stroke risk might be significant, even after adjusting for MBP. The impacts of awake MBP and sleep PP on stroke risk were independent of each other, even after adjusting for covariates.
Impact of Silent Cerebral Infarcts
Silent cerebral infarct are predominantly small lacunar infarcts with various types of pathogenesis including microathoeroembolism, hemodynamic infarction, and arteriosclerosis of small penetrating arteries. In the present study, the presence of SCI was a powerful predictor of future stroke. This association was independent of all parameters of PP and MBP. On the other hand, the positive association between sleep and 24-h PPs and stroke risk was independent of the presence or absence of SCI. Thus, our study indicates that in the elderly hypertensive patients, both large vessel disease (increase in PP) and small vessel disease (SCI) determine the risk of future stroke independently of each other.
There was a positive association between all PP parameters (clinic, 24-h, awake, and sleep) and SCI. However, after adjusting for covariates, this association was not independent of MBP. In contrast, all MBP parameters were determinants for SCI independently of PP parameters. These results may imply that the steady BP overload (MBP) is main determinant for the progression of arteriosclerosis of small cerebral arteries resulting in the formation of small lacunar infarcts than the pulsatile component (PP) in hypertensive patients.
Fatal Cardiovascular Events
Because of the small number of fatal stroke events in this study, we combined the fatal stroke and cardiac events as fatal cardiovascular events. All PP parameters (clinic, 24-h, awake, and sleep) had stronger effects on the fatal cardiovascular events than MBP parameters. The impact of PP may be greater on fatal events than nonfatal cardiovascular events in elderly hypertensives.
In conclusion, in older hypertensive patients, APP, particularly during the sleep period, is an important predictor for future stroke risk, independent of age and ambulatory MBP. Antihypertensive therapy targeting the reduction of the pulsatile component of BP in addition to reducing the steady component may achieve more effective reduction of stroke risk.
